node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
BNIP3L | EBAG9 | ENSECAP00000036882 | ENSECAP00000007630 | BCL2 interacting protein 3 like. | Receptor-binding cancer antigen expressed on SiSo cells; May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases. | 0.628 |
BNIP3L | FTCD | ENSECAP00000036882 | ENSECAP00000010172 | BCL2 interacting protein 3 like. | Formimidoyltransferase cyclodeaminase. | 0.565 |
BNIP3L | RAB9B | ENSECAP00000036882 | ENSECAP00000019457 | BCL2 interacting protein 3 like. | RAB9B, member RAS oncogene family. | 0.705 |
EBAG9 | BNIP3L | ENSECAP00000007630 | ENSECAP00000036882 | Receptor-binding cancer antigen expressed on SiSo cells; May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases. | BCL2 interacting protein 3 like. | 0.628 |
EBAG9 | ESR1 | ENSECAP00000007630 | ENSECAP00000020141 | Receptor-binding cancer antigen expressed on SiSo cells; May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases. | Estrogen receptor; Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE- independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial a [...] | 0.641 |
EBAG9 | FTCD | ENSECAP00000007630 | ENSECAP00000010172 | Receptor-binding cancer antigen expressed on SiSo cells; May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases. | Formimidoyltransferase cyclodeaminase. | 0.795 |
EBAG9 | HEXA | ENSECAP00000007630 | ENSECAP00000050535 | Receptor-binding cancer antigen expressed on SiSo cells; May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases. | Beta-hexosaminidase. | 0.565 |
EBAG9 | KCNG1 | ENSECAP00000007630 | ENSECAP00000043455 | Receptor-binding cancer antigen expressed on SiSo cells; May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases. | Potassium voltage-gated channel modifier subfamily G member 1; Belongs to the potassium channel family. | 0.827 |
EBAG9 | KCNH2 | ENSECAP00000007630 | ENSECAP00000029665 | Receptor-binding cancer antigen expressed on SiSo cells; May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases. | Potassium voltage-gated channel subfamily H member 2. | 0.549 |
EBAG9 | LSP1 | ENSECAP00000007630 | ENSECAP00000047021 | Receptor-binding cancer antigen expressed on SiSo cells; May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases. | Lymphocyte specific protein 1. | 0.576 |
EBAG9 | OPRK1 | ENSECAP00000007630 | ENSECAP00000012142 | Receptor-binding cancer antigen expressed on SiSo cells; May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases. | Opioid receptor kappa 1; Belongs to the G-protein coupled receptor 1 family. | 0.570 |
EBAG9 | RAB9B | ENSECAP00000007630 | ENSECAP00000019457 | Receptor-binding cancer antigen expressed on SiSo cells; May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases. | RAB9B, member RAS oncogene family. | 0.671 |
EBAG9 | SLC22A11 | ENSECAP00000007630 | ENSECAP00000023281 | Receptor-binding cancer antigen expressed on SiSo cells; May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases. | Solute carrier family 22 member 11. | 0.840 |
ESR1 | EBAG9 | ENSECAP00000020141 | ENSECAP00000007630 | Estrogen receptor; Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE- independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial a [...] | Receptor-binding cancer antigen expressed on SiSo cells; May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases. | 0.641 |
FTCD | BNIP3L | ENSECAP00000010172 | ENSECAP00000036882 | Formimidoyltransferase cyclodeaminase. | BCL2 interacting protein 3 like. | 0.565 |
FTCD | EBAG9 | ENSECAP00000010172 | ENSECAP00000007630 | Formimidoyltransferase cyclodeaminase. | Receptor-binding cancer antigen expressed on SiSo cells; May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases. | 0.795 |
FTCD | RAB9B | ENSECAP00000010172 | ENSECAP00000019457 | Formimidoyltransferase cyclodeaminase. | RAB9B, member RAS oncogene family. | 0.644 |
HEXA | EBAG9 | ENSECAP00000050535 | ENSECAP00000007630 | Beta-hexosaminidase. | Receptor-binding cancer antigen expressed on SiSo cells; May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases. | 0.565 |
KCNG1 | EBAG9 | ENSECAP00000043455 | ENSECAP00000007630 | Potassium voltage-gated channel modifier subfamily G member 1; Belongs to the potassium channel family. | Receptor-binding cancer antigen expressed on SiSo cells; May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases. | 0.827 |
KCNG1 | KCNH2 | ENSECAP00000043455 | ENSECAP00000029665 | Potassium voltage-gated channel modifier subfamily G member 1; Belongs to the potassium channel family. | Potassium voltage-gated channel subfamily H member 2. | 0.487 |